Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Olanzepine-induced neuroleptic malignant syndrome in a case of multiple sclerosis.
Paraneoplastic neuromyelitis optica spectrum disorder associated with stomach carcinoid tumor.
Oxidative damage to mitochondria at the nodes of Ranvier precedes axon degeneration in ex vivo transected axons.
CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity.
The Link between CD6 and Autoimmunity: Genetic and Cellular Associations.
Expression of Lymphatic Markers in the Adult Rat Spinal Cord.
Differential efficacy of the TSPO ligands etifoxine and XBD-173 in two rodent models of Multiple Sclerosis.
Technical developments of functional electrical stimulation to correct drop foot: Sensing, actuation and control strategies.
Control of Human PLP1 Expression Through Transcriptional Regulatory Elements and Alternatively Spliced Exons in Intron 1.
Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.
Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology.
The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis.
Certified occupational therapy assistants.
Activation of NOD2/RIPK2 pathway induces mitochondrial injury to oligodendrocyte precursor cells in vitro and CNS demyelination in vivo.
Structural correlates of subjective and objective memory performance in multiple sclerosis.
AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.
Protein-based classifier to predict conversion from clinically isolated syndrome to multiple sclerosis.
Effects of whole body vibration on hormonal & functional indices in patients with multiple sclerosis.
TLR4-activated microglia require IFN-γ to induce severe neuronal dysfunction and death in situ.
Altered resting-state functional connectivity in cognitively preserved pediatric-onset MS patients and relationship to structural damage and cognitive performance.
Endogenous recovery after brain damage; molecular mechanisms that balance neuronal life/death fate.
CLINICAL PROBLEM-SOLVING. A Breakthrough Diagnosis.
Myeloradicular Form of Neuroschistosomiasis in a Six-Year-Old Boy Infected With Schistosoma mansoni.
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes.
Pages
« first
‹ previous
…
493
494
495
496
497
498
499
500
501
…
next ›
last »